{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01079",
      "entity_text" : "AT1R",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0095" ],
      "Species" : [ "taxonomy:10116" ]
    }
  },
  "verbose_text" : "At 40 weeks, persistent lower AT1R levels were observed in all the treatment groups with the exception of SHRSP-Aml6, with SHRSP-Los16 exhibiting the best effects (P < 0.05, SHRSP-Los16 vs. SHRSP-Los6; P < 0.05, SHRSP-Los16 vs. SHRSP-Aml16).",
  "reading_complete" : "2020-08-02T11:06:31Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T11:03:35Z",
  "trigger" : "levels",
  "evidence" : [ "AT1R levels" ],
  "pmc_id" : "3896471",
  "score" : 0
}